Medite Cancer Diagnostics Inc Overview
Update this profile
Medite Cancer Diagnostics Inc General Information
Description
Medite Cancer Diagnostics Inc is a US-based company which specializes in the marketing and selling of MEDITE core products (instruments and consumables), manufacturing, development of new solutions in histology and cytology and marketing of molecular biomarkers. The company manufactures medical devices and consumables are for detection, risk assessment and diagnosis of cancerous and precancerous conditions and related diseases. Medite operates through the single segment for cancer diagnostics instruments and consumables for histology and cytology laboratories. It offers a range of histology laboratory devices for processing tissue, from receiving the tissue in the laboratory to the final diagnosis.
Contact Information
Want to dig into this profile?
We’ll help you find what you need
Learn more
Medite Cancer Diagnostics Inc Valuation & Funding
Deal Type
Date
Amount
Valuation/ EBITDA
Post-Val
Status
Debt
This information is available in the PitchBook Platform. To explore Medite Cancer Diagnostics Inc‘s full profile, request access.
Request a free trial
Medite Cancer Diagnostics Inc Patents
194
Total Documents
Applications and Grants
000
Total Patents
Families
000
Granted
1
Pending
000
Expiring
in next 12 mo
Medite Cancer Diagnostics Inc Recent Patent Activity
Publication ID
Patent Title
Status
First Filing Date
Technology (CPC)
Citations
US-9880156-B2
Biological specimen evaluation methods using cytology and immunology
Expired - Fee Related
11-Apr-2013
00000000000
US-20160033482-A1
Biological specimen evaluation methods using cytology and immunology
Granted
11-Apr-2013
00000000000
EP-2984487-A4
Biological specimen evaluation methods using cytology and immunology
Granted
11-Apr-2013
00000000000
0
ES-2735994-T3
Method to estimate the risk of dysplasia evolving into cancer in a subject
Active
11-Apr-2013
00000000000
EP-2984487-B1
Method for estimating the risk of dysplasia progressing to cancer in a subject
Not-In-Force
11-Apr-2013
G01N33/5091
To view Medite Cancer Diagnostics Inc’s complete patent history, request access »
Medite Cancer Diagnostics Inc Signals
Growth Rate
0.80%
Weekly Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial
Medite Cancer Diagnostics Inc Former Investors
Investor Name
Investor Type
Holding
Investor Since
Participating Rounds
Contact Info
This information is available in the PitchBook Platform. To explore Medite Cancer Diagnostics Inc‘s full profile, request access.
Request a free trial